🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

The Surveillance Clinical Study of Rickettsiosis

Recruitingn/aAges any - anyAllGamaleya Research Institute of Epidemiology and M…
NCT06162975 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The purpose of this surveillance (non-interventional) clinical study is to genotype the causative agents of rickettsioses in biological samples of patients from the regions of Russia. This is a solely observational study in the patients with diagnosed or suspected tick-borne rickettsioses, with no intervention to the routine treatment and diagnostic process. During the study the medical history, diseases progress and symptoms, as well as treatments are being registered in individual case report forms. The rests of the samples used for standard diagnostics (blood, plasma, buffy coat, or serum, and/or swab of the eschar) are being collected and afterwards analyzed for rickettsial genotypes. These data are being compared to the medical history and symptoms of the patients in order to identify clinical patterns specific for causative agents of rickettsioses. Informed consent from all patient

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: To be included in the study, the subject must meet all the following criteria: * Written informed consent by the subject (or their legal representative) to participate in the study; * Men and women of any age, including children, who: have sought medical care (outpatient or inpatient) with suspected or diagnosed rickettsiosis; or have sought medical care (inpatient) with a history of tick bites and elevated body temperature (at least 37.2 °C lasting at least 48 hours). Exclusion Criteria: \- Inability or unwillingness of the subject (or their legal representative) to participate in the study
💊

What it tests

  • Not listed
📍

Where

24 sites
Chemal District Hospital
Chemal, Russia
Center for AIDS Prophylaxis and Treatment
Gorno-Altaysk, Russia
Choya District Hospital
Gusevka, Russia
Kosh-Agach District Hospital
Kosh-Agach, Russia
Mayma District Hospital
Mayma, Russia
Onguday District Hospital
Onguday, Russia
Ust-Kan District Hospital
Ust'-Kan, Russia
Ust-Koksa District Hospital
Ust'-Koksa, Russia

…and 16 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy